Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation.

OBJECTIVES Using human pathologic specimens from the CVPath registry, we aimed to investigate the location of the atherosclerotic plaque at bifurcation in native coronary atherosclerotic lesions and to determine the responses at bifurcation after implantation of bare-metal stents (BMS) and drug-eluting stents (DES). BACKGROUND Greater atherosclerotic plaque burden has been reported to occur at low-shear regions of bifurcation. METHODS Twenty-six randomly selected human atherosclerotic nonstented coronary bifurcation lesions were examined longitudinally for plaque distribution in patients dying of severe coronary artery disease. Forty stented bifurcation lesions (21 BMS and 19 DES) were reviewed and analyzed by morphometry. RESULTS In nonstented coronary bifurcations, the lateral wall showed significantly greater intima as well as necrotic core thickness than the flow divider. In the stented lesion, the frequency of late stent thrombosis was greater in the DES group (75%) than in the BMS group (36%), whereas restenosis was more frequent in the BMS group (33%) than in the DES group (5%). Neointimal formation was significantly less at the flow divider compared with the lateral wall in the DES group (0.07 mm [interquartile range (IQR) 0.03 to 0.15 mm] vs. 0.17 mm [IQR 0.09 to 0.23 mm]; p = 0.001), whereas this difference was not significant in the BMS group. Similarly, uncovered struts and fibrin deposition was significantly greater at the flow divider compared with the lateral wall in the DES group (uncovered: 40% [IQR 16% to 76%] vs. 0% [IQR 0% to 15%]; p = 0.001; fibrin: 60% [IQR 21% to 67%] vs. 17% [IQR 0% to 55%]; p = 0.01), but not in the BMS group. CONCLUSIONS Plaque formation in native coronary bifurcations and neointimal growth after DES implantation was significantly less at the flow divider versus the lateral wall. A higher prevalence of late stent thrombosis in DES compared with BMS was associated with greater uncovered struts at flow divider sites, which is likely due to flow disturbances.

[1]  E. Edelman,et al.  Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. , 2004, The Journal of clinical investigation.

[2]  Renu Virmani,et al.  Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans , 2003, Circulation.

[3]  M. H. Friedman,et al.  Influence of curvature dynamics on pulsatile coronary artery flow in a realistic bifurcation model. , 2004, Journal of biomechanics.

[4]  D. Liepsch,et al.  Flow visualization and 1- and 3-D laser-Doppler-anemometer measurements in models of human carotid arteries. , 1998, Clinical hemorheology and microcirculation.

[5]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[6]  Johan Lindbäck,et al.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. , 2007, The New England journal of medicine.

[7]  Gregg W Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[8]  Seung‐Jung Park,et al.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.

[9]  A. Tzafriri,et al.  Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents , 2005, Circulation.

[10]  M. Bell,et al.  Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. , 2000, Journal of the American College of Cardiology.

[11]  A. Tzafriri,et al.  Luminal flow patterns dictate arterial drug deposition in stent-based delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[12]  A. Farb,et al.  Stent thrombosis redux--the FDA perspective. , 2007, The New England journal of medicine.

[13]  Antonio Colombo,et al.  Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.

[14]  L. Antiga,et al.  Geometry of the Carotid Bifurcation Predicts Its Exposure to Disturbed Flow , 2008, Stroke.

[15]  Michael M. Resch,et al.  Pulsatile non-Newtonian blood flow in three-dimensional carotid bifurcation models: a numerical study of flow phenomena under different bifurcation angles. , 1991, Journal of biomedical engineering.

[16]  David O. Williams,et al.  Outcomes and complications associated with off-label and untested use of drug-eluting stents. , 2007, JAMA.

[17]  Rob Krams,et al.  Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. , 2005, Blood.

[18]  I. Seong,et al.  Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease , 2006, Circulation.

[19]  B. Fox,et al.  Distribution of fatty and fibrous plaques in young human coronary arteries. , 1982, Atherosclerosis.

[20]  Renu Virmani,et al.  Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.

[21]  J. Tobis,et al.  Bifurcation lesions: two stents versus one stent--immediate and follow-up results. , 2000, Journal of the American College of Cardiology.

[22]  Gregg W. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease , 2004 .

[23]  A. Svindland,et al.  Localization of atherosclerotic lesions in the bifurcation of the main left coronary artery. , 1983, Atherosclerosis.

[24]  B. Gersh.  Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents , 2006 .

[25]  K. Peterson,et al.  Atheroma morphology and distribution in proximal left anterior descending coronary artery: in vivo observations. , 1996, Journal of the American College of Cardiology.

[26]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[27]  S. Yazdani,et al.  DPIV measurements of flow disturbances in stented artery models: adverse affects of compliance mismatch. , 2004, Journal of biomechanical engineering.

[28]  D. Ku,et al.  Pulsatile Flow and Atherosclerosis in the Human Carotid Bifurcation: Positive Correlation between Plaque Location and Low and Oscillating Shear Stress , 1985, Arteriosclerosis.

[29]  B. Berk,et al.  Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[30]  G. Hutchins,et al.  Correlation between wall shear and intimal thickness at a coronary artery branch. , 1987, Atherosclerosis.

[31]  S. Pocock,et al.  Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.

[32]  J D Hellums,et al.  Morphological, biochemical, and functional changes in human platelets subjected to shear stress. , 1975, The Journal of laboratory and clinical medicine.

[33]  F. Grosveld,et al.  Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress , 2006, Circulation.

[34]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[35]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.